Shigeru Harasawa

A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome

Kei Matsueda, Shigeru Harasawa, Michio Hongo et al. · Scandinavian Journal of Gastroenterology · 2008 · 124 citations

Medicine, Pharmacology, Pharmacotherapy +16

A Phase II Trial of the Novel Serotonin Type 3 Receptor Antagonist Ramosetron in Japanese Male and Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome

Kei Matsueda, Shigeru Harasawa, Michio Hongo et al. · Digestion · 2008 · 87 citations

Medicine, Pharmacology, Pharmacotherapy +15

Gastric emptying in normal subjects and patients with peptic ulcer

Shigeru Harasawa, Norio Tani, Sotaro Suzuki et al. · Gastroenterologia Japonica · 1979 · 63 citations

Medicine, Clinical Sciences, Internal Medicine +12

Large‐scale randomized clinical study on functional dyspepsia treatment with mosapride or teprenone: Japan Mosapride Mega‐Study (JMMS)

Michio Hongo, Shigeru Harasawa, Tetsuya Mine et al. · Journal of Gastroenterology and Hepatology · 2011 · 53 citations

Medicine, Pharmacology, Pharmacotherapy +16

High Prevalence of Irritable Bowel Syndrome in Medical Outpatients in Japan

Masae Shinozaki, Shin Fukudo, Michio Hongo et al. · Journal of Clinical Gastroenterology · 2008 · 50 citations

Medicine, Health Sciences, Internal Medicine +13